Provision of abortion medications using online asynchronous telemedicine under shield laws in the US

JAMA Network

Facebook

XLinkedInWeChatBlueskyMessageWhatsAppEmail

About The Study: This study analyzes use of online asynchronous telemedicine abortion services for the period July 2023 through September 2024 via data from a nonprofit asynchronous telemedicine service that provides abortion medications throughout the U.S.

Corresponding Author: To contact the corresponding author, Abigail R. A. Aiken, PhD, email araa2@utexas.edu.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jama.2025.11420)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

Embed this link to provide your readers free access to the full-text article 

https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2025.11420?guestAccessKey=2d73bd0a-4f31-4966-8938-1a18c78e56ee&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=081125

---

Journal

JAMA